Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Inflammatory Bowel Diseases

Free Subscription 23.09.2019 1 Aliment Pharmacol Ther 1 Dig Dis Sci 1 J Gastroenterol 1 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aliment Pharmacol Ther

1. DAI C, Jiang M, Sun MJ
   Letter: increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFalpha agents, particularly etanercept, for autoimmune diseases other than IBD.
   Aliment Pharmacol Ther. 2019;50:834-835.
   PubMed     Text format    
   
   

   
   Dig Dis Sci

2. GHOSH S, Bressler B, Petkau J, Thakkar RB, et al
   Healthcare Providers Underestimate Patients' Glucocorticoid Use in Crohn's Disease.
   Dig Dis Sci. 2019;64:1142-1149.
   PubMed     Text format     Abstract available
   
   

   
   J Gastroenterol

3. NAGANUMA M, Sugimoto S, Fukuda T, Mitsuyama K, et al
   Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study.
   J Gastroenterol. 2019 Sep 16. pii: 10.1007/s00535-019-01625.
   PubMed     Text format     Abstract available
   
   

   
   Scand J Gastroenterol

4. MALHAM M, Carlsen K, Riis L, Paerregaard A, et al
   Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis.
   Scand J Gastroenterol. 2019 Sep 17:1-6. doi: 10.1080/00365521.2019.1665097.
   PubMed     Text format     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: